News and Press Releases Archives - Page 6 of 10 - World Stem Cell Summit World Stem Cell Summit

January 22, 2018

Longeveron Alzheimer’s Disease Trial

Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients with Alzheimer’s Disease. Longeveron’s Phase I, prospective, randomized, placebo-controlled, double-blinded study is designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed Alzheimer’s disease. Longeveron has completed the FDA mandated safety run in and […]

January 22, 2018

Longeveron Aging Frailty Phase 2b Trial

Longeveron is currently enrolling subjects in its Phase 2b multi-center clinical trial designed to test the safety and efficacy of Longeveron Mesenchymal Stem Cells (LMSCs) for the treatment of subjects with clinically diagnosed with Aging Frailty. This is the only known trial in the world underway to use MSCs to treat Aging Frailty. Frailty is […]

January 21, 2018

Avalon GloboCare Corp. CEO David Jin, M.D., Ph.D. to Present and Chair the “China’s Impact on The World of Regenerative Medicine” Session at the 13th Annual World Stem Cell Summit

PRESS RELEASE Marketwired Jan. 21, 2018, 08:20 AM FREEHOLD, NJ (Marketwired – January 21, 2018) – Avalon GloboCare Corp. (OTCQB: AVCO), a leading global developer of cell-based technologies, announced today that President and Chief Executive Officer David Jin, M.D., Ph.D. will chair a session entitled, “China’s impact on the world of regenerative medicine,” and provide […]

January 19, 2018

Mayo Clinic Center for Regenerative Medicine at the 2018 World Stem Cell Summit

The Mayo Clinic Center for Regenerative Medicine is a co-organizer of the 2018 World Stem Cell Summit. More than 1,000 attendees are expected at the 13th annual event Jan. 22-26 in Miami, Florida. Researchers and clinical experts from Mayo Clinic will participate in presentations and panel discussions highlighting advances in discovery science, promising clinical trials […]

January 18, 2018

California’s Stem Cell Agency Invests in Phase 3 Clinical Trial to Help Kidney Transplant Patients

Posted: January 18, 2018 January 18, 2018 – Oakland, CA Over 650,000 Americans suffer from end-stage kidney disease – a life-threatening condition caused by the loss of kidney function. The best available treatment for these patients is a kidney transplant from a genetically matched, living donor. However, patients who receive a transplant must take life-long […]

January 18, 2018

The Making of a Stem Cell Super-Ecosystem with Bernard Siegel

January 17, 2018 By Cade Hildreth (CEO) Leave a Comment I am honored to share this interview with Bernard Siegel, Executive Director of the Regenerative Medicine Foundation (RMF), a global network of stakeholders that fosters collaboration across the industry. Bernard is also the Founder and Chair of the World Stem Cell Summit (WSCS), my favorite […]

January 18, 2018

Pioneers of Hope: Patient Advocate Doug Oliver’s Interview of Dr. Francis Collins, Director, National Institutes of Health (NIH)

The Regenerative Outcomes Foundation is proud to present the Pioneers of Hope, a series of our founder Doug Oliver’s personal interviews with leading influencers in the Regenerative Medicine movement. These articles are our way of sharing the hope that this field promises to all, from top legislators, great policy minds, researchers, patients, and providers, as […]

January 18, 2018

AgeX CEO Michael D. West to Present in Plenary Session at The World Stem Cell Summit on “Stem Cell Innovations That Will Change the World”

ALAMEDA, Calif.–(BUSINESS WIRE)–AgeX Therapeutics, Inc., a subsidiary of BioTime, Inc. (NYSE American: BTX), today announced that AgeX will present in a Plenary session, “Stem Cell Innovations That Will Change the World – Part 2,” at the World Stem Cell Summit (WSCS) on Thursday, January 25, 2018 at the Hyatt Regency Miami. AgeX CEO Michael D. […]

January 17, 2018

NSU to present at World Stem Cell Summit

By Christina Mclaughlin – January 16, 2018 Researchers and faculty members from NSU’s College of Allopathic Medicine (M.D. College) will present their research in the fields of cancer immunotherapy and regenerative medicine at the 2018 World Stem Cell Summit from Jan. 22-26 at the Hyatt Regency in Miami. There will be 10 NSU representatives from […]

January 15, 2018

Collaboration With Explosive Upside! World Stem Cell Summit- Phacilitate Cell & Gene Therapy World And Immuno-Oncology Frontiers World

Dear Colleagues, Twelve years ago my nonprofit organization, Genetics Policy Institute (now Regenerative Medicine Foundation) founded an annual conference that evolved into the World Stem Cell Summit. Over time, this event has brought together thousands of thought leaders and stakeholders from around the globe. All came with a shared passion, to expand their knowledge, forge […]

January 14, 2018

World Stem Cell Summit And Phacilitate Cell & Gene Therapy World Present: Emerging Science Track

World Stem Cell Summit and Phacilitate are proud to present a the 3-day EMERGING SCIENCE track covering ONCOLOGY, TRANSLATIONAL & CLINICAL UPDATE and GENE THERAPY FOR RARE DISEASES. Thirty of world’s leading experts cover the following topics: Reprogramming The Tumor Microenvironment: Conquering Immune Suppressive Molecular Pathways Engineering The Next Frontier In Cellular Immunotherapy: Looking Beyond […]